TrialClinical and experimental immunology2014

Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis.

K Migita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.